Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Proton pump inhibitors and fracture risk. The HUNT study, Norway.

Hoff M, Skovlund E, Skurtveit S, Meyer HE, Langhammer A, Søgaard AJ, Syversen U, Forsmo S, Abrahamsen B, Schei B.

Osteoporos Int. 2019 Nov 18. doi: 10.1007/s00198-019-05206-0. [Epub ahead of print]

PMID:
31741023
2.

Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants.

Binding C, Bjerring Olesen J, Abrahamsen B, Staerk L, Gislason G, Nissen Bonde A.

J Am Coll Cardiol. 2019 Oct 29;74(17):2150-2158. doi: 10.1016/j.jacc.2019.08.1025.

PMID:
31648707
3.

Age at hip fracture and life expectancy in Denmark - Secular trends over two decades.

Abrahamsen B, Laursen HVB, Skjødt MK, Jensen MH, Vestergaard P.

Bone. 2020 Jan;130:115083. doi: 10.1016/j.bone.2019.115083. Epub 2019 Oct 14.

PMID:
31622776
4.

The Latest Evidence from Vitamin D Intervention Trials for Skeletal and Non-skeletal Outcomes.

Sami A, Abrahamsen B.

Calcif Tissue Int. 2019 Sep 28. doi: 10.1007/s00223-019-00616-y. [Epub ahead of print]

PMID:
31563967
5.

Tramadol prescribed use in general and chronic noncancer pain: a nationwide register-based cohort study of all patients above 16 years.

Hansen CA, Ernst MT, Stougaard M, Abrahamsen B.

Scand J Pain. 2019 Sep 17. pii: /j/sjpain.ahead-of-print/sjpain-2019-0114/sjpain-2019-0114.xml. doi: 10.1515/sjpain-2019-0114. [Epub ahead of print]

PMID:
31527300
6.

Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study.

Glintborg D, Rubin KH, Nybo M, Abrahamsen B, Andersen M.

Endocr Connect. 2019 Oct 1;8(10):1405-1415. doi: 10.1530/EC-19-0377.

7.

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF).

Hiligsmann M, Cornelissen D, Vrijens B, Abrahamsen B, Al-Daghri N, Biver E, Brandi ML, Bruyère O, Burlet N, Cooper C, Cortet B, Dennison E, Diez-Perez A, Gasparik A, Grosso A, Hadji P, Halbout P, Kanis JA, Kaufman JM, Laslop A, Maggi S, Rizzoli R, Thomas T, Tuzun S, Vlaskovska M, Reginster JY.

Osteoporos Int. 2019 Nov;30(11):2155-2165. doi: 10.1007/s00198-019-05104-5. Epub 2019 Aug 7.

8.

Fracture risk following intermission of osteoporosis therapy.

Dennison EM, Cooper C, Kanis JA, Bruyère O, Silverman S, McCloskey E, Abrahamsen B, Prieto-Alhambra D, Ferrari S; IOF Epidemiology/Quality of Life Working Group.

Osteoporos Int. 2019 Sep;30(9):1733-1743. doi: 10.1007/s00198-019-05002-w. Epub 2019 Jun 7.

PMID:
31175404
9.

Excess mortality following hip fracture in patients with diabetes according to age: a nationwide population-based cohort study of 154,047 hip fracture patients.

Madsen CM, Jantzen C, Norring-Agerskov D, Vojdeman FJ, Abrahamsen B, Lauritzen JB, Jørgensen HL.

Age Ageing. 2019 Jul 1;48(4):559-563. doi: 10.1093/ageing/afz048.

PMID:
31081511
10.

Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk.

Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L.

Eur J Endocrinol. 2019 Jun 1;180(6):407-416. doi: 10.1530/EJE-19-0006.

PMID:
31035256
11.

Lack of Transparency in the Meta-Analyses of Dietary and Urinary Sodium and Bone Mineral Density or Risk of Osteoporosis: A Letter to the Journal.

Cardoso I, Michalowska J, Larsen SC, Abrahamsen B, Heitmann BL, Händel MN.

J Am Coll Nutr. 2019 Nov-Dec;38(8):746-747. doi: 10.1080/07315724.2019.1590250. Epub 2019 Apr 16. No abstract available.

PMID:
30990773
12.

Pre-fracture medication use as a predictor of 30-day mortality in hip fracture patients: an analysis of 141,201 patients.

Jantzen C, Madsen CM, Abrahamsen B, Van Der Mark S, Duus BR, Howland J, Lauritzen JB, Jørgensen HL.

Hip Int. 2019 Mar 1:1120700019832603. doi: 10.1177/1120700019832603. [Epub ahead of print]

PMID:
30821177
13.

Osteoporosis and prostate cancer; a 24-month prospective observational study during androgen deprivation therapy.

Poulsen MH, Frost M, Abrahamsen B, Gerke O, Walter S, Lund L.

Scand J Urol. 2019 Feb;53(1):34-39. doi: 10.1080/21681805.2019.1570328. Epub 2019 Feb 19.

PMID:
30777478
14.

Biochemical markers of inflammation are associated with increased mortality in hip fracture patients: the Bispebjerg Hip Fracture Biobank.

Norring-Agerskov D, Bathum L, Pedersen OB, Abrahamsen B, Lauritzen JB, Jørgensen NR, Jørgensen HL.

Aging Clin Exp Res. 2019 Dec;31(12):1727-1734. doi: 10.1007/s40520-019-01140-7. Epub 2019 Feb 1.

PMID:
30707355
15.

Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular Risk.

Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L.

Thyroid. 2019 Mar;29(3):332-340. doi: 10.1089/thy.2018.0320. Epub 2019 Feb 13.

PMID:
30648498
16.

Hip fracture rates and time trends in use of anti-osteoporosis medications in Denmark for the period 2005 to 2015: Missed opportunities in fracture prevention.

Abrahamsen B, Skjødt MK, Vestergaard P.

Bone. 2019 Mar;120:476-481. doi: 10.1016/j.bone.2018.12.016. Epub 2018 Dec 21.

PMID:
30583122
17.

Does bisphosphonate treatment reduce the risk of future cancer?

Pazianas M, Abrahamsen B.

Chin Clin Oncol. 2019 Oct;8(S1):S3. doi: 10.21037/cco.2018.10.08. Epub 2018 Oct 27. No abstract available.

18.

[Phytoestrogens as a dietary supplement].

Olsen A, Kyrø C, Schwarz P, Vestergaard P, Lidegaard Ø, Hermann P, Langdahl B, Beck Jensen JE, Abrahamsen B, Harsløf T.

Ugeskr Laeger. 2018 Dec 3;180(49). pii: V04180286. Danish.

PMID:
30520719
19.

Socioeconomic status in Danish women with polycystic ovary syndrome: A register-based cohort study.

Rubin KH, Andersen MS, Abrahamsen B, Glintborg D.

Acta Obstet Gynecol Scand. 2019 Apr;98(4):440-450. doi: 10.1111/aogs.13514. Epub 2018 Dec 23.

PMID:
30516823
20.

Vitamin D supplementation for musculoskeletal health outcomes in adults - The end of the beginning?

Abrahamsen B, Harvey NC.

Maturitas. 2019 Apr;122:87-88. doi: 10.1016/j.maturitas.2018.10.011. Epub 2018 Oct 25. No abstract available.

21.

Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report.

Byberg S, Abrahamsen B, Kassem M, Ralston S, Schwarz P.

J Med Case Rep. 2018 Sep 27;12(1):278. doi: 10.1186/s13256-018-1820-y.

22.

High calcium intake in men not women is associated with all-cause mortality risk: Melbourne Collaborative Cohort Study.

Rodríguez AJ, Scott D, Khan B, Hodge A, English DR, Giles GG, Abrahamsen B, Ebeling PR.

Arch Osteoporos. 2018 Sep 21;13(1):101. doi: 10.1007/s11657-018-0518-5.

PMID:
30242518
23.

A longitudinal study of nurses' career choices: The importance of career expectations on employment in care of older people.

Abrahamsen B.

J Adv Nurs. 2019 Feb;75(2):348-356. doi: 10.1111/jan.13847. Epub 2018 Oct 11.

PMID:
30209827
24.

Side effects of drugs for osteoporosis and metastatic bone disease.

Skjødt MK, Frost M, Abrahamsen B.

Br J Clin Pharmacol. 2019 Jun;85(6):1063-1071. doi: 10.1111/bcp.13759. Epub 2018 Oct 17. Review.

PMID:
30192026
25.

Long term time trends in use of medications associated with risk of developing osteoporosis: Nationwide data for Denmark from 1999 to 2016.

Skjødt MK, Ostadahmadli Y, Abrahamsen B.

Bone. 2019 Mar;120:94-100. doi: 10.1016/j.bone.2018.08.019. Epub 2018 Aug 30.

PMID:
30172013
26.

Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.

Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N.

Endocr Rev. 2019 Apr 1;40(2):333-368. doi: 10.1210/er.2018-00001. Review.

PMID:
30169557
27.

Diagnosis and management of bone fragility in diabetes: an emerging challenge.

Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, El-Hajj Fuleihan G, Josse R, Kendler DL, Kraenzlin M, Suzuki A, Pierroz DD, Schwartz AV, Leslie WD; Bone and Diabetes Working Group of IOF.

Osteoporos Int. 2018 Dec;29(12):2585-2596. doi: 10.1007/s00198-018-4650-2. Epub 2018 Jul 31. Review.

28.

Persistence of Excess Mortality Following Individual Nonhip Fractures: A Relative Survival Analysis.

Tran T, Bliuc D, Hansen L, Abrahamsen B, van den Bergh J, Eisman JA, van Geel T, Geusens P, Vestergaard P, Nguyen TV, Center JR.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3205-3214. doi: 10.1210/jc.2017-02656.

PMID:
30053007
29.

Social inequality and fractures-secular trends in the Danish population: a case-control study.

Hansen L, Judge A, Javaid MK, Cooper C, Vestergaard P, Abrahamsen B, Harvey NC.

Osteoporos Int. 2018 Oct;29(10):2243-2250. doi: 10.1007/s00198-018-4603-9. Epub 2018 Jun 26.

30.

A New Fracture Risk Assessment Tool (FREM) Based on Public Health Registries.

Rubin KH, Möller S, Holmberg T, Bliddal M, Søndergaard J, Abrahamsen B.

J Bone Miner Res. 2018 Nov;33(11):1967-1979. doi: 10.1002/jbmr.3528. Epub 2018 Aug 22.

31.

Effects of the excitatory amino acid transporter subtype 2 (EAAT-2) inducer ceftriaxone on different pain modalities in rat.

Eljaja L, Bjerrum OJ, Honoré PH, Abrahamsen B.

Scand J Pain. 2018 Jul 1;2(3):132-136. doi: 10.1016/j.sjpain.2011.03.003.

PMID:
29913736
32.

Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.

Hoff M, Skurtveit S, Meyer HE, Langhammer A, Søgaard AJ, Syversen U, Skovlund E, Abrahamsen B, Forsmo S, Schei B.

Osteoporos Int. 2018 Aug;29(8):1875-1885. doi: 10.1007/s00198-018-4560-3. Epub 2018 May 17.

PMID:
29774403
33.

Over- and Under-Treatment of Hypothyroidism Is Associated with Excess Mortality: A Register-Based Cohort Study.

Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L.

Thyroid. 2018 May;28(5):566-574. doi: 10.1089/thy.2017.0517. Epub 2018 Apr 26.

PMID:
29631518
34.

The Changing Role of Patient Education in Osteoporosis.

Abrahamsen B.

J Bone Miner Res. 2018 May;33(5):761-762. doi: 10.1002/jbmr.3425. Epub 2018 Apr 17. No abstract available.

35.

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.

Glintborg D, Rubin KH, Nybo M, Abrahamsen B, Andersen M.

Cardiovasc Diabetol. 2018 Mar 8;17(1):37. doi: 10.1186/s12933-018-0680-5.

36.

Lactose avoidance and bone.

Abrahamsen B, Vestergaard P.

Maturitas. 2018 Mar;109:A1-A2. doi: 10.1016/j.maturitas.2017.11.004. Epub 2017 Nov 3. No abstract available.

PMID:
29150063
37.

Response to Letter to the Editor: "Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome".

Glintborg D, Rubin KH, Abrahamsen B, Andersen M.

J Clin Endocrinol Metab. 2018 Jan 1;103(1):362-363. doi: 10.1210/jc.2017-02123. No abstract available.

PMID:
29126200
38.

The emperor redressed: treating osteoporosis to prevent hip fractures in the oldest old.

Abrahamsen B.

J Intern Med. 2017 Dec;282(6):560-562. doi: 10.1111/joim.12700. No abstract available.

39.
40.

Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome.

Rubin KH, Glintborg D, Nybo M, Abrahamsen B, Andersen M.

J Clin Endocrinol Metab. 2017 Oct 1;102(10):3848-3857. doi: 10.1210/jc.2017-01354.

PMID:
28938447
41.

Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.

Kanis JA, Cooper C, Rizzoli R, Abrahamsen B, Al-Daghri NM, Brandi ML, Cannata-Andia J, Cortet B, Dimai HP, Ferrari S, Hadji P, Harvey NC, Kraenzlin M, Kurth A, McCloskey E, Minisola S, Thomas T, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Osteoporos Int. 2017 Nov;28(11):3285-3286. doi: 10.1007/s00198-017-4161-6. No abstract available.

42.

Bespoke or one size fits all-Vitamin D fortification, targeted supplementation in risk groups or individual measurement?

Abrahamsen B.

Maturitas. 2017 Sep;103:1-2. doi: 10.1016/j.maturitas.2017.06.001. Epub 2017 Jun 4. No abstract available.

PMID:
28778326
43.

Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study.

Martinez-Laguna D, Nogues X, Abrahamsen B, Reyes C, Carbonell-Abella C, Diez-Perez A, Prieto-Alhambra D.

Osteoporos Int. 2017 Sep;28(9):2573-2581. doi: 10.1007/s00198-017-4096-y. Epub 2017 Jul 25.

PMID:
28744600
44.

Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.

Hoff M, Meyer HE, Skurtveit S, Langhammer A, Søgaard AJ, Syversen U, Dhainaut A, Skovlund E, Abrahamsen B, Schei B.

Osteoporos Int. 2017 Oct;28(10):2935-2944. doi: 10.1007/s00198-017-4134-9. Epub 2017 Jul 1.

PMID:
28668994
45.

Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.

Eiken PA, Prieto-Alhambra D, Eastell R, Abrahamsen B.

Osteoporos Int. 2017 Oct;28(10):2921-2928. doi: 10.1007/s00198-017-4132-y. Epub 2017 Jun 29.

PMID:
28664276
46.

Neonatal vitamin D status from archived dried blood spots and future risk of fractures in childhood: results from the D-tect study, a population-based case-cohort study.

Händel MN, Frederiksen P, Cohen A, Cooper C, Heitmann BL, Abrahamsen B.

Am J Clin Nutr. 2017 Jul;106(1):155-161. doi: 10.3945/ajcn.116.145599. Epub 2017 May 17.

PMID:
28515065
47.

The risk of osteoporosis in oral steroid treatment for nasal polyposis: a systematic review.

Winblad L, Larsen CG, Håkansson K, Abrahamsen B, von Buchwald C.

Rhinology. 2017 Sep 1;55(3):195-201. doi: 10.4193/Rhin15.367.

PMID:
28492609
48.

The calcium and vitamin D controversy.

Abrahamsen B.

Ther Adv Musculoskelet Dis. 2017 May;9(5):107-114. doi: 10.1177/1759720X16685547. Epub 2017 Mar 26. Review.

49.

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.

Kanis JA, Cooper C, Rizzoli R, Abrahamsen B, Al-Daghri NM, Brandi ML, Cannata-Andia J, Cortet B, Dimai HP, Ferrari S, Hadji P, Harvey NC, Kraenzlin M, Kurth A, McCloskey E, Minisola S, Thomas T, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Osteoporos Int. 2017 Jul;28(7):2023-2034. doi: 10.1007/s00198-017-4009-0. Epub 2017 Apr 27. Erratum in: Osteoporos Int. 2017 Aug 7;:.

50.

Prenatal exposure to vitamin D from fortified margarine and risk of fractures in late childhood: period and cohort results from 222 000 subjects in the D-tect observational study.

Händel MN, Frederiksen P, Osmond C, Cooper C, Abrahamsen B, Heitmann BL.

Br J Nutr. 2017 Mar;117(6):872-881. doi: 10.1017/S000711451700071X. Epub 2017 Apr 10.

Supplemental Content

Loading ...
Support Center